Former Alabama wide receiver John Metchie III was diagnosed with leukemia after being drafted in the second round by the Texans in April.
Houston Texans rookie wide receiver John Metchie III announced Sunday that he has been diagnosed with a form of leukemia., Metchie says he is getting treatment for acute promyelocytic leukemia, “the most curable form," and expects “to make a recovery at a later point in time.”
“As a result of this diagnosis, I will likely not be playing football this season,” Metchie said. “My main focus will be on my health and recovery. ... I cannot wait to come back stronger than ever.” Metchie went 44th in the second round of this year's NFL draft out of Alabama, where he had 96 receptions for 1,142 yards and eight touchdowns last season for the Crimson Tide. He tore his left ACLStay informed about local news and weather in Southern California. Get the NBC LA app for
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Texans rookie wide receiver John Metchie III diagnosed with rare form of cancerHe says he was diagnosed with acute promyelocytic leukemia, a rare blood cancer, and will...
続きを読む »
Former Tide player, Texans WR John Metchie III diagnosed with leukemiaMetchie said he would likely miss the upcoming football season as his primary focus will be on his health and recovery.
続きを読む »
Texans John Metchie III diagnosed with LeukemiaCurrent Texans wide receiver and former Alabama wide receiver John Metchie III, has released a statement on Twitter saying he has been diagnosed with APL, or Acute Promyelocytic Leukemia.
続きを読む »
Texans rookie John Metchie diagnosed with leukemia, likely to miss 2022 seasonHouston Texans rookie wide receiver John Metchie III has been diagnosed with a form of leukemia and will likely miss what would have been his first season in the NFL, Metchie announced on Sunday.
続きを読む »
Ranking the new NFL alternate helmets so far from best (Falcons) to worst (Texans)Ranking all the new NFL alternate helmets that have been revealed so far this offseason.
続きを読む »